Omega-3 polyunsaturated fatty acids reduce kidney aging and fibrosis through activation of the FFAR4 receptor in tubular cells, a mechanism that declines with age and in chronic kidney disease. Loss of FFAR4 accelerates renal aging, positioning this receptor as a therapeutic target for preserving kidney function across the lifespan.
Key Points
- FFAR4 activation by omega-3 PUFAs suppresses tubular cell senescence and kidney fibrosis
- FFAR4 expression declines in aged kidneys and correlates with renal dysfunction
- FFAR4 knockout aggravates renal aging through impaired Klotho signaling and senescence control
Longevity Analysis
The kidney's capacity to filter waste and regulate blood composition depends on maintaining tubular epithelial cell function across decades. This research identifies a specific receptor-ligand interaction that preserves cellular vitality in the kidney tubules—the functional units most vulnerable to aging-related decline. The decline of FFAR4 signaling with age represents a decoding failure: the tissue loses its ability to respond to circulating omega-3 signals that normally suppress cellular senescence. Restoring this communication pathway through targeted omega-3 interventions or receptor agonism addresses a root mechanism of age-related kidney disease rather than treating downstream symptoms. For individuals with declining renal function, identifying low FFAR4 responsiveness may enable stratified intervention before overt chronic kidney disease develops.
Original published by Wiley Aging Cell, by Letian Yang, Lei Tang, Jian Li, Dekai Liu, Chunchun Hu, Fan Guo, Lin Lin, Rongshuang Huang, Ping Fu, Liang Ma .